The clinical implications of the prostate cancer prevention trial

BJU Int. 2003 Nov;92(7):667-71. doi: 10.1046/j.1464-410x.2003.04486.x.
No abstract available

Publication types

  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Aged
  • Diagnostic Errors
  • Double-Blind Method
  • Enzyme Inhibitors / therapeutic use*
  • Finasteride / therapeutic use*
  • Humans
  • Incidence
  • Male
  • Middle Aged
  • Prostate-Specific Antigen / blood
  • Prostatic Neoplasms / mortality
  • Prostatic Neoplasms / pathology
  • Prostatic Neoplasms / prevention & control*
  • Randomized Controlled Trials as Topic
  • Treatment Outcome

Substances

  • Enzyme Inhibitors
  • Finasteride
  • Prostate-Specific Antigen